Reviewing the journey to the clinical application of bacteriophages to treat multi-drug-resistant bacteria
Description
Antimicrobial resistance (AMR) was a leading cause of death globally in 2019. Sadly, COVID-19 has exacerbated AMR, nonetheless, the process of developing new antibiotics remains very challenging. This urgently requires the adoption of alternative
